EP Patent

EP3723809A1 — Methods for treating gaucher disease

Assigned to Genzyme Corp · Expires 2020-10-21 · 6y expired

What this patent protects

Methods for treating Gaucher disease in patients with renal or hepatic impairment.

USPTO Abstract

Methods for treating Gaucher disease in patients with renal or hepatic impairment.

Drugs covered by this patent

Patent Metadata

Patent number
EP3723809A1
Jurisdiction
EP
Classification
—
Expires
2020-10-21
Drug substance claim
No
Drug product claim
No
Assignee
Genzyme Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.